BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4888575)

  • 21. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
    Linker CA; Ries CA; Damon LE; Rugo HS; Wolf JL
    Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Autologous mononuclear bone marrow cell transplantation by intracoronary route for patients with ischemic heart disease: observation of 2-years follow-up].
    Gao LR; Wang ZG; Tian HT; Zhu ZM; Fei YX; Xu HT; Chen Y; Zhu JR; He S; Zhang NK; Ding QA; Yang Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):685-9. PubMed ID: 17553306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients.
    Hirji Z; Saragosa R; Dedier H; Crump M; Franke N; Burrows L; Jamieson F; Brown S; Gardam MA
    Clin Infect Dis; 2003 May; 36(10):e115-21. PubMed ID: 12746790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spleen and bone marrow shielding technique in intraoperative adjuvant chemotherapy for gastric cancer.
    Inokuchi K; Nakamura T; Ienaga S; Akiyoshi T; Ikeda T
    J Antibiot (Tokyo); 1966 Mar; 19(2):78-84. PubMed ID: 5952896
    [No Abstract]   [Full Text] [Related]  

  • 26. Decreased bone mineral density is common after autologous blood or marrow transplantation.
    Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
    Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I-II study of high-dose mitomycin with autologous bone marrow transplantation in refractory metastatic breast cancer.
    Tannir N; Spitzer G; Dicke K; Schell F; DiStefano A; Blumenschein G
    Cancer Treat Rep; 1984 May; 68(5):805-6. PubMed ID: 6426793
    [No Abstract]   [Full Text] [Related]  

  • 28. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
    Gu Y; Zhang J; Qi L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2 in autologous bone marrow transplantation.
    Charak BS
    Natl Med J India; 1993; 6(1):19-22. PubMed ID: 8453356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy with autologous bone marrow transplantation for the treatment of breast cancer: yes.
    Peters WP
    Important Adv Oncol; 1995; ():215-30. PubMed ID: 7672808
    [No Abstract]   [Full Text] [Related]  

  • 32. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course.
    Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D
    Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multipotent mesenchymal stromal cells of the autologous bone marrow accelerate healing indolent gastric ulcers].
    Askarov MB; Shumakov VI; Onishchenko NA
    Vestn Khir Im I I Grek; 2009; 168(2):22-6. PubMed ID: 19514387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow as multidimensional orbit oscillator after autologous bone marrow transplantation.
    Hajek D; Kubesova H; Vyzula R; Mayer J; Druckmueller M; Tomiska M; Vasku A
    Stem Cells; 1999; 17(1):25-30. PubMed ID: 10215398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infectious complications the year after autologous bone marrow transplantation or peripheral stem cell transplantation for treatment of breast cancer.
    Barton T; Collis T; Stadtmauer E; Schuster M
    Clin Infect Dis; 2001 Feb; 32(3):391-5. PubMed ID: 11170946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. IL-3 BMT Study Team.
    Schulman KA; Dorsainvil D; Yabroff KR; DiCesare J; Felser J; Eisenberg JM; Glick HA
    Bone Marrow Transplant; 1998 Mar; 21(6):607-14. PubMed ID: 9543065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
    Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
    Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective combined off-pump surgical treatment and autologous bone marrow cell transplantation: a new alternative for patients with end-stage ischemic cardiomyopathy (Prapas' procedure).
    Prapas S; Protogeros D; Danou F; Trikka C; Panagiotopoulos I; Chandrinou H
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():101-7. PubMed ID: 19028642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human antibody SC-1 reduces disseminated tumor cells in nude mice with human gastric cancer.
    Illert B; Otto C; Vollmers HP; Hensel F; Thiede A; Timmermann W
    Oncol Rep; 2005 Apr; 13(4):765-70. PubMed ID: 15756455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.